ImmuPharma PLC (IMM)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
3.11p
Buy
3.60p
-0.08p (-2.33%)
ImmuPharma PLC is a drug discovery and development company. The company along with its subsidiaries is engaged in the research and development of novel drugs based on peptide therapeutics to treat serious medical conditions including autoimmune diseases.
Prices updated at 16 May 2025, 16:30 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Share price chart
Please note that past performance is not a reliable indicator of future returns.